Comparison of the incidence and risk factors of acute respiratory illness associated with COVID-19 and influenza
Authors: Huang QS et al., on behalf of the SHIVERS investigation team
Summary: Vaccination, age, ethnicity, and household size are independent protective/ risk factors for COVID-19 and influenza in New Zealand, according to results of the SHIVERS II, III and IV Prospective Community Cohort Study. Over the period 7 February to 2 October 2022, the adjusted cumulative incidence for COVID-19 in Wellington was 4.5 times higher than for influenza. For COVID-19, the highest incidence was seen in adolescents aged 12-17 years and individuals of European/other ethnicity. For influenza, the highest incidence was seen in children aged 1-4 years and Māori. Risk of COVID-19 infection was 75% higher in adolescents who had received two doses of the COVID-19 vaccine vs adults who had received three doses. Individuals with COVID-19 were less likely to access health care or experience febrile and severe illness than those with influenza, but were more likely to report sore throat, headache, myalgia, and loss of taste or smell.
Reference: J Infect Dis. 2025 Aug;232(2):450-464.
Abstract
The burden of HMPV- and influenza-associated hospitalizations in adults in New Zealand before and after the COVID-19 pandemic
Authors: Aminisani N et al.
Summary: A surveillance study of adults (aged ≥20 years) hospitalised with acute respiratory infections in Auckland between 2012 and 2023 found that those aged ≥80 years, of Māori or Pacific ethnicity, and living in low socioeconomic status areas had the highest hospitalisation rates for both influenza and human metapneumovirus (HMPV). Crude hospitalisation rates were 9.7 per 100 000 adults (95% CI 9.0-10.4) for HMPV and 48.2 (95% CI 46.6-49.7) for influenza. HMPV-associated hospitalisation rates were not significantly different before and after the COVID-19 pandemic, but influenza-associated hospitalisation increased from 43.0 per 100 000 adults before the pandemic, to 54.4 in 2022 and 79.5 in 2023.
Reference: J Infect Dis. 2025 Jul;232(Supplement_1):S47-S58.
Abstract
Variation in clinical presentation, complications and outcomes for Māori and Pacific peoples among hospitalised adults with COVID-19 in 2022
Authors: Maze MJ et al.
Summary: Among adults (≥16 years) hospitalised with COVID-19 at 11 New Zealand hospitals between January and May 2022, Māori and Pacific individuals were younger at presentation, and had a lower vaccination rate and a higher risk of complications than non-Māori, non-Pacific (NMNP) individuals. Median age was 52, 57 and 63 years for Māori, Pacific and NMNP individuals, respectively. Corresponding rates of vaccination (≥2 doses) were 73.4%, 76.7% and 84.8%. Māori had a greater risk of acute kidney injury, cardiac arrhythmia, shock, myocardial infarction, cardiac arrest and acute respiratory distress syndrome compared with NMNP individuals, while Pacific individuals had a greater risk of acute kidney injury and pneumonia, and a lower risk of thromboembolism and myocarditis/pericarditis. There were no differences in age-standardised mortality between ethnic groups.
Reference: Intern Med J. 2025 Aug;55(8):1339-1349.
Abstract